UNE COMBINAISON D'UNE PREPARATION LIPOSOMALE CATIONIQUE RENFERMANT UN AGENT ANTIMITOTIQUE ET UNE PREPARATION NON LIPOSOMALE RENFERMANT UN AGENT ANTIMITOTIQUE
Antimitotic agents that can be used for the treatment of triple receptornegativebreast cancer can exhibit low water solubility which can make it difficult toproduce ina suitable dosage form. The present invention relates to the use of acombination ofa cationic liposomal preparation comprising at least one cationic lipid, afirstantimitotic agent and optionally at least one neutral and/or anionic lipid;and a non-liposomalpreparation comprising a second antimitotic agent, for simultaneous,separate and/or sequential administration to a human or an animal.